Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) FCF Margin (2020 - 2026)

GeneDx Holdings has reported FCF Margin over the past 7 years, most recently at 37.48% for Q1 2026.

  • Quarterly FCF Margin fell 4664.0% to 37.48% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 4.36% through Mar 2026, down 247.0% year-over-year, with the annual reading at 6.31% for FY2025, 1649.0% up from the prior year.
  • FCF Margin was 37.48% for Q1 2026 at GeneDx Holdings, down from 4.38% in the prior quarter.
  • Over five years, FCF Margin peaked at 9.17% in Q1 2025 and troughed at 237.81% in Q2 2022.
  • The 5-year median for FCF Margin is 37.48% (2026), against an average of 60.12%.
  • Year-over-year, FCF Margin crashed -18823bps in 2022 and then surged 12797bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 94.8% in 2022, then skyrocketed by 47bps to 50.11% in 2023, then soared by 93bps to 3.49% in 2024, then soared by 225bps to 4.38% in 2025, then tumbled by -957bps to 37.48% in 2026.
  • Per Business Quant, the three most recent readings for WGS's FCF Margin are 37.48% (Q1 2026), 4.38% (Q4 2025), and 5.87% (Q3 2025).